More signs we could be entering a new era of vaccine abundance, if only we can persuade people to use them.
Will a new wave of RSV vaccines stop the dangerous virus?
Pfizer, GSK and Moderna are ahead in the race to produce vaccines against respiratory syncytial virus — what will be their impact?
nature.com